VCAM1 and stroke disorder: Our findings align with those of Justicia et al. 2006, who found that blocking VCAM-1 in an ischaemic mouse model alters the composition of the infiltrating leukocytes (by reducing monocyte infiltration and increasing neutrophils and lymphocytes), which might not necessarily be beneficial for the outcome of stroke.